Medicine information
उपयोग
ST GLIPTIN 2 is an oral antidiabetic medicine marketed by Steris Healthcare, containing Sitagliptin IP 25 mg. Sitagliptin belongs to a class of medicines known as dipeptidyl peptidase-4 (DPP-4) inhibitors, which help regulate blood glucose levels in people with type 2 diabetes mellitus. Sitagliptin works by increasing the activity of incretin hormones, which help regulate insulin release in response to meals and reduce the amount of glucose produced by the body when blood sugar levels are elevated. This mechanism supports blood glucose management when used as prescribed by a qualified healthcare professional. ST GLIPTIN 2 may be prescribed as part of an individualized diabetes treatment plan, together with a balanced diet, regular physical activity, and routine blood glucose monitoring. The 25 mg strength is commonly used in patients who require a reduced dose, such as certain patients with significantly impaired kidney function. The appropriate dose should be determined by the treating physician based on the patient's condition and renal function.
कैसे उपयोग करें
Take ST GLIPTIN 2 exactly as prescribed by your doctor. Follow the recommended dose and schedule provided by your healthcare professional. Sitagliptin can generally be taken with or without food, but you should follow the instructions on your product packaging and prescription. Do not change the dosage or discontinue treatment without medical advice. Continue following your recommended meal plan, exercise routine, and blood glucose monitoring schedule. Inform your doctor if you miss a dose; do not take an extra dose to compensate unless instructed by your healthcare professional.
भंडारण
Store ST GLIPTIN 2 according to the instructions printed on the product packaging. Keep the tablets in their original packaging, protected from excessive heat, moisture, and direct sunlight. Keep the medicine out of the reach of children. Do not use the tablets after the expiry date, and dispose of unused or expired medicine responsibly according to local pharmaceutical disposal guidance.
